http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020521021-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2851 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-065 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B59-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2896 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-02007 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01T1-161 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-02 |
| filingDate | 2018-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2020521021-A |
| titleOfInvention | CD206+ macrophage-specific molecular imaging probe compositions and methods, and non-invasive quantification of arterial wall macrophage infiltration in humans |
| abstract | Described herein are compositions and methods for diagnosing, imaging, and quantifying non-calcified atherosclerotic plaque. Embodiments of the compositions described herein include, in addition to other carbohydrate molecules, mannosylated dextran compounds that include, for example, diagnostic agents and moieties. The compounds and methods embodied herein provide excellent localization and results for imaging, anatomically locating and quantifying non-calcified atherosclerotic plaques. [Selection diagram] Figure 2 |
| priorityDate | 2017-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 120.